Download presentation
Presentation is loading. Please wait.
Published byZoe Briggs Modified over 6 years ago
1
Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer
Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya Takamochi, MD, Shiaki Oh, MD, Kenji Suzuki, MD The Annals of Thoracic Surgery Volume 104, Issue 1, Pages (July 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Typical images of radiologically invasive non-small cell lung cancer (NSCLC) for (A) ground glass opacity (GGO)-predominant and (B) solid-predominant part-solid lung cancer and (C) pure-solid lung cancer. (CTR = consolidation tumor ratio.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Five-year (A) overall survival and (B) recurrent-free survival revealed significant differences between pure-solid and part-solid non-small cell lung cancers. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 The 5-year overall survival based on the maximum tumor size differed significantly among the (A) clinical stage IA radiologic pure-solid non-small cell lung cancers (NSCLCs). However, it was irrelevant to the prognosis in patients with (B) radiologic part-solid NSCLCs. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
5
Fig 4 Among the patients with radiologically invasive part-solid lung cancers, (A) no significant differences were observed for the 5-year overall survival (OS) between the ground glass opacity (GGO)-predominant and solid-predominant arms. Subsequently, (B) the 5-year OS was almost equivalent regardless of solid component size. (CTR = consolidation tumor ratio.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.